Discover
CLGN
CollPlant Biotechnologies Ltd.
3.51
30 x 0.12
10 x 3.76
bid
ask
-
0.46
11.59%
20 @ 04:00 PM
3.51 +0.00 (0.00%)
| Ytd | -74.93% | |
| 1y | -85.00% |
3.51
day range
4.13
2.73
52 week range
24.90
| Open | 3.87 | Prev Close | 3.97 | Low | 3.51 | High | 4.13 | Mkt Cap | 6.64M |
| Vol | 182.35K | Avg Vol | 352.86K | EPS | -9.33 | P/E | N/A | Forward P/E | -8.82 |
| Beta | 0.48 | Short Ratio | 0.70 | Inst. Own | 12.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-25 | 50-d Avg | 3.46 | 200-d Avg | 5.99 | 1yr Est | 12.50 |
| Income Statement | |||
| Total Revenue | 108.00K | ||
| Revenues (USD) | 108.00K | ||
| Cost of Revenue | 564.00K | ||
| Gross Profit | -456.00K | ||
| Operating Expenses | 2.18M | ||
| Research and Development Expense | 1.17M | ||
| Selling, General and Administrative Expense | 1.01M | ||
| Operating Income | -2.63M | ||
| Net Income | -2.73M | ||
| Net Income Common Stock | -2.73M | ||
| Net Income Common Stock (USD) | -2.73M | ||
| Consolidated Income | -2.73M | ||
| Earnings per Basic Share | -1.89 | ||
| Earnings per Basic Share (USD) | -1.89 | ||
| Earnings per Diluted Share | -1.89 | ||
| Earning Before Interest & Taxes (EBIT) | -2.73M | ||
| Earning Before Interest & Taxes (USD) | -2.73M | ||
| Weighted Average Shares | 1.44M | ||
| Weighted Average Shares Diluted | 1.44M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.56M | ||
| Cash and Equivalents (USD) | 2.56M | ||
| Trade and Non-Trade Receivables | 16.00K | ||
| Current Assets | 3.90M | ||
| Property, Plant & Equipment Net | 3.17M | ||
| Total Assets | 7.20M | ||
| Debt Current | 894.00K | ||
| Total Debt | 2.66M | ||
| Current Liabilities | 2.49M | ||
| Debt Non-Current | 1.77M | ||
| Total Liabilities | 4.25M | ||
| Accumulated Retained Earnings (Deficit) | -130.66M | ||
| Accumulated Other Comprehensive Income | -969.00K | ||
| Shareholders Equity | 2.95M | ||
| Shareholders Equity (USD) | 2.95M | ||
| Assets Non-Current | 3.30M | ||
| Total Debt (USD) | 2.66M | ||
| Goodwill and Intangible Assets | 45.00K | ||
| Inventory | 540.00K | ||
| Liabilities Non-Current | 1.77M | ||
| Trade and Non-Trade Payables | 256.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 197.00K | ||
| Net Cash Flow from Financing | 620.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.70M | ||
| Capital Expenditure | 14.00K | ||
| Issuance (Purchase) of Equity Shares | 620.00K | ||
| Net Cash Flow from Investing | 14.00K | ||
| Net Cash Flow from Operations | -2.33M | ||
| Effect of Exchange Rate Changes on Cash | -4.00K | ||
| Share Based Compensation | 165.00K | ||